Maternal neutralizing antibody and transmission of hepatitis C virus to infants

Journal of Infectious Diseases

Volumn 198, Issue 11, 2008, Pages 1651-1655

  Dowd, Kimberly A ^a   Hershow, Ronald C ^d   Yawetz, Sigal ^e   LaRussa, Philip ^f   Diaz, Clemente ^h   Landesman, Sheldon H ^g   Paul, Mary E ⁱ   Read, Jennifer S ^c   Lu, Ming ^b   Thomas, David L ^a   Netski, Dale M ^a   Ray, Stuart C ^a,j  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b Clinical Trials and Surveys   (United States)

^c EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^d UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

^f Columbia University ^*  (United States)

^g BROOKDALE UNIVERSITY HOSPITAL AND MEDICAL CENTER   (United States)

^h UNIVERSITY OF PUERTO RICO   (Puerto Rico)

ⁱ BAYLOR COLLEGE OF MEDICINE   (United States)

^j JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

NEUTRALIZING ANTIBODY;

ANTIBODY TITER; ARTICLE; COMORBIDITY; CONTROLLED STUDY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INFANT; MAJOR CLINICAL STUDY; MATERNAL PLASMA; MIXED INFECTION; PLACENTAL TRANSFER; PRIORITY JOURNAL; VIRUS PARTICLE; VIRUS TRANSMISSION;

ADULT; FEMALE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HIV INFECTIONS; HUMANS; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RISK FACTORS;

EID: 56649112957     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/593067     Document Type: Article

References (15)

1. Mast EE, Hwang LY, Seto DS, et al. Risk factors for perinatal transmission of hepatitis C virus (HCV) and the natural history of HCV infection acquired in infancy. J Infect Dis 2005; 192:1880-9.
2. Thomas DL, Villano SA, Riester KA, et al. Perinatal transmission of hepatitis C virus from human immunodeficiency virus type 1-infected mothers. J Infect Dis 1998; 177:1480-8.
3. Zanetti AR, Tanzi E, Paccagnini S, et al. Mother-to-infant transmission of hepatitis C virus. Lancet 1995; 345:289-91.
4. Netski DM, Mosbruger T, Depla E, et al. Humoral immune response in acute hepatitis C virus infection. Clin Infect Dis 2005; 41:667-75.
5. Cox AL, Mosbruger T, Mao Q, et al. Cellular immune selection with hepatitis C virus persistence in humans. J Exp Med 2005; 201:1741-52.
6. Bartosch B, Dubuisson J, Cosset FL. Infectious hepatitis C virus pseudoparticles containing functional E1-E2 envelope protein complexes. J Exp Med 2003; 197:633-42.
7. Hsu M, Zhang J, Flint M, et al. Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles. Proc Natl Acad Sci USA 2003; 100:7271-6.
8. Logvinoff C, Major ME, Oldach D, et al. Neutralizing antibody response during acute and chronic hepatitis C virus infection. Proc Natl Acad Sci USA 2004; 101:10149-54.
9. Lavillette D, Morice Y, Germanidis G, et al. Human serum facilitates hepatitis C virus infection, and neutralizing responses inversely correlate with viral replication kinetics at the acute phase of hepatitis C virus infection. J Virol 2005; 79:6023-34.
10. Pestka JM, Zeisel MB, Blaser E, et al. Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C. Proc Natl Acad Sci USA 2007; 104:6025-30.
11. Meunier JC, Engle RE, Faulk K, et al. Evidence for cross-genotype neutralization of hepatitis C virus pseudo-particles and enhancement of infectivity by apolipoprotein C1. Proc Natl Acad Sci USA 2005; 102:4560-5.
12. + T cell-dependent reduction in hepatitis C virus-specific humoral immune responses after HIV infection. J Infect Dis 2007; 195:857-63.
13. Hershow RC, Riester KA, Lew J, et al. Increased vertical transmission of human immunodeficiency virus from hepatitis C virus-coinfected mothers. J Infect Dis 1997; 176:414-20.
14. Bartosch B, Bukh J, Meunier JC, et al. In vitro assay for neutralizing antibody to hepatitis C virus: evidence for broadly conserved neutralization epitopes. Proc Natl Acad Sci USA 2003; 100:14199-204.
15. von Hahn T, Yoon JC, Alter H, et al. Hepatitis C virus continuously escapes from neutralizing antibody and T-cell responses during chronic infection in vivo. Gastroenterology 2007; 132:667-78.